Bridgewater Associates’s NuVasive, Inc. NUVA Stock Holding History

Bridgewater Associates’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-57,499	Closed	-$2.39M	–	824
2023 Q2	$2.39M	Sell	57,499 -6,183	-10%	-$254K	0.01%	436
2023 Q1	$2.63M	Buy	63,682 +2,402	+4%	+$103K	0.02%	420
2022 Q4	$2.53M	Sell	61,280 -20,895	-25%	-$846K	0.01%	495
2022 Q3	$3.6M	Sell	82,175 -104	-0.1%	-$5.04K	0.02%	447
2022 Q2	$4.04M	Buy	82,279 +8,027	+11%	+$431K	0.02%	540
2022 Q1	$4.21M	Buy	74,252 +17,579	+31%	+$934K	0.02%	510
2021 Q4	$2.97M	Buy	56,673 +8,243	+17%	+$448K	0.02%	405
2021 Q3	$2.9M	Sell	48,430 -3,855	-7%	-$238K	0.02%	375
2021 Q2	$3.54M	Buy	+52,285	New	+$3.57M	0.02%	397

Other funds holding NUVA

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Bridgewater Associates's NUVA Position: Q3 2023 in Review

Bridgewater Associates sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 57,499 shares — an estimated $2.39M sold.

Bridgewater Associates first reported a position in NUVA in Q2 2021 and held it in 9 quarters. The position peaked at $4.21M in Q1 2022. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

Bridgewater Associates reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
Bridgewater Associates sold 57,499 NuVasive, Inc. shares in Q3 2023, an estimated $2.39M.
Bridgewater Associates first reported a position in NuVasive, Inc. in Q2 2021 and held it in 9 quarters.
Bridgewater Associates's NuVasive, Inc. position peaked at $4.21M in Q1 2022.
2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Bridgewater Associates's 13F filing for Q3 2023, filed 13 Nov 2023.